Share on StockTwits

Leerink Swann dropped their target price on shares of Alere (NYSE:ALR) from $40.00 to $38.00 in a research note issued on Tuesday. The firm currently has a “market perform” rating on the stock. Leerink Swann’s price target would indicate a potential upside of 5.85% from the company’s current price.

Other equities research analysts have also recently issued reports about the stock. Analysts at Canaccord Genuity cut their price target on shares of Alere from $50.00 to $45.00 in a research note on Tuesday. Separately, analysts at Zacks upgraded shares of Alere from an “underperform” rating to a “neutral” rating in a research note on Thursday, July 10th. They now have a $38.70 price target on the stock. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $41.95.

Shares of Alere (NYSE:ALR) traded up 3.31% during mid-day trading on Tuesday, hitting $35.90. 1,552,890 shares of the company’s stock traded hands. Alere has a 52-week low of $29.61 and a 52-week high of $40.80. The stock’s 50-day moving average is $38.13 and its 200-day moving average is $36.34. The company’s market cap is $2.965 billion.

Alere (NYSE:ALR) last released its earnings data on Monday, August 4th. The company reported $0.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by $0.16. The company had revenue of $738.30 million for the quarter, compared to the consensus estimate of $747.55 million. During the same quarter in the previous year, the company posted $0.64 earnings per share. The company’s revenue for the quarter was down 3.4% on a year-over-year basis. Analysts expect that Alere will post $2.52 EPS for the current fiscal year.

Alere Inc is a provider of point-of-care diagnostics and services. The Company’s products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.